CUBIST PHARMACEUTICALS INC Interest Expense, Debt, Excluding Amortization
CUBIST PHARMACEUTICALS INC reported Interest Expense, Debt, Excluding Amortization of $13.37 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-25.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2014-02-25
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for the quarter ending 2012-12-31 was $2.90M, a 15.22% decline year-over-year.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for the quarter ending 2012-09-30 was $3.02M, a 12.02% decline year-over-year.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for the quarter ending 2012-06-30 was $3.33M, a 3.14% decline year-over-year.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for the quarter ending 2012-03-31 was $3.43M, a 0.03% increase year-over-year.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for fiscal 2013 was $13.37M, a 5.55% increase from fiscal 2012.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for fiscal 2012 was $12.67M, a 7.59% decline from fiscal 2011.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for fiscal 2011 was $13.71M, a 70.53% increase from fiscal 2010.
- CUBIST PHARMACEUTICALS INC interest expense, debt, excluding amortization for fiscal 2010 was $8.04M, a 18.21% increase from fiscal 2009.
| Period end | Interest Expense, Debt, Excluding Amortization 3 month | Interest Expense, Debt, Excluding Amortization 6 month | Interest Expense, Debt, Excluding Amortization 9 month | Interest Expense, Debt, Excluding Amortization 12 month |
|---|---|---|---|---|
| 2013-12-31 | $13.37M 10-K · filed 2014-02-25 | |||
| 2012-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $5.91M derived: sum of 2 quarters · filed 2014-02-25 | $9.24M derived: sum of 3 quarters · filed 2014-02-25 | $12.67M 10-K · filed 2014-02-25 |
| 2012-09-30 | $3.02M 10-Q · filed 2012-11-05 | $6.34M derived: sum of 2 quarters · filed 2012-11-05 | $9.77M 10-Q · filed 2012-11-05 | $13.19M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $3.33M 10-Q · filed 2012-08-07 | $6.75M 10-Q · filed 2012-08-07 | $10.17M derived: sum of 3 quarters · filed 2014-02-25 | $13.60M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $3.43M 10-Q · filed 2012-05-01 | $6.84M derived: sum of 2 quarters · filed 2014-02-25 | $10.27M derived: sum of 3 quarters · filed 2014-02-25 | $13.71M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $6.84M derived: sum of 2 quarters · filed 2014-02-25 | $10.28M derived: sum of 3 quarters · filed 2014-02-25 | $13.71M 10-K · filed 2014-02-25 |
| 2011-09-30 | $3.43M 10-Q · filed 2012-11-05 | $6.86M derived: sum of 2 quarters · filed 2012-11-05 | $10.29M 10-Q · filed 2012-11-05 | $13.26M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $3.44M 10-Q · filed 2012-08-07 | $6.86M 10-Q · filed 2012-08-07 | $9.84M derived: sum of 3 quarters · filed 2013-02-27 | $11.52M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $3.43M 10-Q · filed 2012-05-01 | $6.40M derived: sum of 2 quarters · filed 2013-02-27 | $8.09M derived: sum of 3 quarters · filed 2013-02-27 | $9.78M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $4.66M derived: sum of 2 quarters · filed 2013-02-27 | $6.35M derived: sum of 3 quarters · filed 2013-02-27 | $8.04M 10-K · filed 2013-02-27 |
| 2010-09-30 | $1.69M 10-Q · filed 2011-11-02 | $3.37M derived: sum of 2 quarters · filed 2011-11-02 | $5.06M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $1.69M 10-Q · filed 2011-07-29 | $3.38M 10-Q · filed 2011-07-29 | ||
| 2009-12-31 | $6.80M 10-K · filed 2012-02-27 |